Jefferies Downgrades Immunocore Holdings to Hold, Lowers Price Target to $33
Benzinga Newsdesk 7 months ago
NewsDowngradesPrice TargetAnalyst Ratings
Jefferies analyst Clara Dong downgrades Immunocore Holdings (NASDAQ:IMCR) from Buy to Hold and lowers the price target from $48 to $33.
Jefferies analyst Clara Dong downgrades Immunocore Holdings (NASDAQ:IMCR) from Buy to Hold and lowers the price target from $48 to $33.